Comparison of the size distributions and immunogenicity of human papillomavirus type 16 L1 virus-like particles produced in insect and yeast cells
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Hyoung Jin | - |
dc.contributor.author | Cho, Seo Young | - |
dc.contributor.author | Park, Min-Hye | - |
dc.contributor.author | Kim, Hong-Jin | - |
dc.date.available | 2019-03-07T04:45:16Z | - |
dc.date.issued | 2018-05 | - |
dc.identifier.issn | 0253-6269 | - |
dc.identifier.issn | 1976-3786 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/2226 | - |
dc.description.abstract | Insect and yeast cells are considered the expression systems of choice for producing virus-like particles (VLPs), and numerous types of VLPs have been produced in these systems. However, previous studies were restricted to identifying the characteristics of individual VLP preparations. No direct comparison of the structures and immunogenic properties of insect and yeast-derived VLPs has so far been made. In the present study, the size distribution and immunogenic properties of human papillomavirus type 16 (HPV16) L1 VLPs produced in Spodoptera frugipedra-9 insect cells and Saccharomyces cerevisiae were compared. The insect cell-derived VLPs were larger than the yeast ones (P < 0.0001), with median sizes of 34 and 26 nm, respectively. In addition, the insect-derived VLPs appeared to be more diverse in size than the yeast-derived VLPs. Immunization of mice with 30 ng per dose of VLPs elicited 2.7- and 2.4-fold higher anti-HPV16 L1 IgG and anti-HPV16 neutralizing antibody titers than immunization with the same amounts of the yeast-derived VLPs after the 4th immunizations, respectively. Our results suggest that the choice of expression system critically affects the particle size and immunogenic property of HPV16 L1 VLPs. | - |
dc.format.extent | 10 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | PHARMACEUTICAL SOC KOREA | - |
dc.title | Comparison of the size distributions and immunogenicity of human papillomavirus type 16 L1 virus-like particles produced in insect and yeast cells | - |
dc.type | Article | - |
dc.identifier.doi | 10.1007/s12272-018-1024-4 | - |
dc.identifier.bibliographicCitation | ARCHIVES OF PHARMACAL RESEARCH, v.41, no.5, pp 544 - 553 | - |
dc.identifier.kciid | ART002351156 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.wosid | 000433540100008 | - |
dc.identifier.scopusid | 2-s2.0-85045139945 | - |
dc.citation.endPage | 553 | - |
dc.citation.number | 5 | - |
dc.citation.startPage | 544 | - |
dc.citation.title | ARCHIVES OF PHARMACAL RESEARCH | - |
dc.citation.volume | 41 | - |
dc.type.docType | Article | - |
dc.publisher.location | 대한민국 | - |
dc.subject.keywordAuthor | Human papillomavirus | - |
dc.subject.keywordAuthor | Virus-like particles | - |
dc.subject.keywordAuthor | Vaccine | - |
dc.subject.keywordAuthor | Immunogenicity | - |
dc.subject.keywordAuthor | Spodoptera frugipedra-9 | - |
dc.subject.keywordAuthor | Saccharomyces cerevisiae | - |
dc.subject.keywordPlus | MAJOR NEUTRALIZING EPITOPE | - |
dc.subject.keywordPlus | CAPSID PROTEIN L1 | - |
dc.subject.keywordPlus | CERVICAL-CANCER | - |
dc.subject.keywordPlus | SACCHAROMYCES-CEREVISIAE | - |
dc.subject.keywordPlus | PURIFICATION | - |
dc.subject.keywordPlus | STABILITY | - |
dc.subject.keywordPlus | VACCINES | - |
dc.subject.keywordPlus | CERVARIX(TM) | - |
dc.subject.keywordPlus | GARDASIL(R) | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.